Načítá se...
Doxorubicin-Induced Cardiomyopathy in Children
Doxorubicin-induced cardiotoxicity in childhood cancer survivors is a growing problem. The population of patients at risk for cardiovascular disease is steadily increasing, as five-year survival rates for all types of childhood cancers continue to improve. Doxorubicin affects the developing heart di...
Uloženo v:
| Vydáno v: | Compr Physiol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7000168/ https://ncbi.nlm.nih.gov/pubmed/31187890 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cphy.c180017 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|